An audit of people admitted to hospital with diabetes and coronavirus (SARS-CoV-2): data collection methods. The Association of British Clinical Diabetologists (ABCD) Nationwide Audit

被引:7
|
作者
Nagi, Dinesh [1 ]
Ryder, Robert E. J. [2 ]
Ruan, Yue [3 ,4 ]
Field, Benjamin C. T. [5 ,6 ]
Narendran, Parth [7 ,8 ]
Gandhi, Rajiv [9 ]
Harris, Sophie [10 ]
Varnai, Kinga A. [4 ,11 ]
Davies, Jim [4 ,12 ]
Wild, Sarah H. [13 ]
Wilmot, Emma G. [14 ,15 ]
Khunti, Kamlesh [16 ]
Rea, Rustam [3 ,4 ]
机构
[1] Mid Yorkshire Hosp NHS Trust, Pinderfields Hosp, Wakefield, England
[2] Sandwell & West Birmingham Hosp NHS Trust, Birmingham, W Midlands, England
[3] Oxford Univ Hosp NHS Fdn Trust, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England
[4] Oxford NIHR Biomed Res Ctr, Oxford, England
[5] Univ Surrey, Fac Hlth & Med Sci, Dept Clin & Expt Med, Guildford, Surrey, England
[6] Surrey & Sussex Healthcare NHS Trust, Dept Diabet & Endocrinol, Redhill, Surrey, England
[7] Univ Birmingham, Med & Dent Sci, Birmingham, W Midlands, England
[8] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Diabet Ctr, Birmingham, W Midlands, England
[9] Sheffield Teaching Hosp NHS Fdn Trust, Dept Diabet & Endocrinol, Sheffield, S Yorkshire, England
[10] Kings Coll Hosp London, Diabet & Endocrinol Dept, London, England
[11] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[12] Univ Oxford, Dept Comp Sci, Oxford, England
[13] Univ Edinburgh, Usher Inst, Edinburgh, Midlothian, Scotland
[14] Univ Hosp Derby & Burton NHS FT, Diabet Dept, Derby, England
[15] Univ Nottingham, Nottingham, England
[16] Univ Hosp Leicester NHS Trust, Leicester Gen Hosp, Diabet Res Ctr, Leicester, Leics, England
来源
BRITISH JOURNAL OF DIABETES | 2021年 / 21卷 / 01期
关键词
COVID-19; diabetes; pandemic; COVID-Audit; risk factors and mortality; ABCD nationwide Audit; TYPE-1; COVID-19;
D O I
10.15277/bjd.2021.299
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe the rationale, aims and objectives and the methodology of data collection for the ABCD nationwide audit of individuals admitted to hospital with coronavirus (SARS-CoV-2; COVID-19) and diabetes. The audit was inspired and undertaken by the urgent need to understand the clinical course of COVID-19 in patients with diabetes admitted to hospital in the UK during the pandemic. We wished to understand the clinical behaviour of diabetes per se, post hospital admission and the factors with may be associated with admission to the Intensive Care Unit (ICU) and death due to COVID-19. This was a clinically-led audit. We used existing infrastructure and expertise to collect data using an electronic tool specifically designed and piloted by the steering group members. The clinical variables were chosen to fulfil the main aim of this audit as stated above, and factors influencing the clinical course of COVID-19 in individuals with both type 1 and type 2 diabetes at the time of admission to hospital and during the whole length of stay, until discharge or death from COVID-19. The data collected so far represent a large, multicentre audit with more than 3,500 admissions during the pandemic. We plan to continue collecting additional data and publish ongoing reports of interest to diabetes clinicians with the aim of enhancing knowledge and understanding and thereby improving clinical care of, and outcomes for, people with diabetes who are admitted to hospital with COVID-19 in the UK.
引用
收藏
页码:96 / +
页数:5
相关论文
共 45 条
  • [31] Intermittently scanned continuous glucose monitoring and hypoglycaemia awareness in drivers with diabetes: Insights from the Association of British Clinical Diabetologists Nationwide audit
    Mark-Wagstaff, Charlotte
    Deshmukh, Harshal
    Wilmot, Emma G.
    Walker, Neil
    Barnes, Dennis
    Parfitt, Vernon
    Saunders, Simon
    Gregory, Rob
    Choudhary, Pratik
    Patmore, Jane
    Walton, Chris
    Ryder, Robert E. J.
    Sathyapalan, Thozhukat
    DIABETES OBESITY & METABOLISM, 2024, 26 (01): : 46 - 53
  • [32] Three years with FreeStyle Libre (FSL) in people living with diabetes: Insights from the Association of British Clinical Diabetologists national audit
    Deshmukh, H.
    Shah, N.
    Wilmot, E. G.
    Walton, C.
    Ryder, R. E. J.
    Sathyapalan, T.
    DIABETIC MEDICINE, 2023, 40
  • [33] Many Benefits of Empagliflozin Persist in Those with Reduced Renal Function: Updated Data from the Association of British Clinical Diabetologists (ABCD) Audit Programme
    Crabtree, Thomas S. J.
    Adamson, Karen
    Bickerton, Alex
    Phillips, Suzanne M.
    Evans, Alison
    Robinson, Anthony M.
    Atkin, Marc
    Morris, David S.
    Williams, David M.
    Stephens, Jeffrey W.
    Sennik, Devesh K.
    Rohilla, Anurita
    Cull, Melissa L.
    Raghavan, Rajeev P.
    Yadagiri, Mahender
    Gallen, Ian W.
    Ryder, Robert E.
    DIABETES, 2020, 69
  • [34] Effect on HbA1c of switching to insulin degludec from another basal insulin: the Association of British Clinical Diabetologists (ABCD) nationwide degludec audit
    Lumb, A. N.
    Rea, R. D.
    Abraham, R.
    McDonald, P.
    Bain, S. C.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2017, 34 : 88 - 89
  • [35] The impact of sodium glucose link transporter-2 inhibitors (SGLT2i) on Fib4 score in patients with type 2 diabetes: Analysis using Association of British Clinical Diabetologists (ABCD) nationwide audit data
    Crabtree, T. S. J.
    Elliott, J.
    Sivappriyan, S.
    Barnes, D.
    Bickerton, A.
    Gallen, I.
    Idris, I.
    Ryder, R. E. J.
    DIABETIC MEDICINE, 2021, 38
  • [36] Does Dapagliflozin Affect the Metabolic Response in Patients with Elevated Alanine Aminotransferase (ALT) and Type 2 Diabetes? The Association of British Clinical Diabetologists Nationwide Dapagliflozin Audit
    Yadagiri, Mahender
    Sen Gupta, Piya
    Cull, Melissa L.
    Price, David
    Oguntolu, Victor
    Imtiaz, Komal
    Barnes, Denis
    Nugent, Ailish
    Robinson, Anthony
    Gallen, Ian W.
    Adamson, Karen A.
    Ryder, Robert E. J.
    DIABETES, 2016, 65 : A293 - A294
  • [37] Insulin treatment and longer diabetes duration both predict poorer glycaemic response to liraglutide treatment in type 2 diabetes: the Association of British Clinical Diabetologists Nationwide Liraglutide Audit
    Thong, Ken Y.
    Mcgowan, Barbara M.
    Htay, Thein
    Pernet, Andrew
    Kelly, Chris
    Rajeswaran, Chinnadorai
    Howell, Jill
    Duncan, Catriona
    Inkster, Berit
    Buchanan, Linda
    Kassim, Saiful
    Nayer, Rahul
    Barwell, Nicholas D.
    Walton, Christopher
    Ryder, Robert E. J.
    BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE, 2015, 15 (04): : 169 - +
  • [38] Previous structured education attendance and the relationship with HbA1c and hypoglycaemia awareness in people living with type 1 diabetes mellitus using Freestyle Libre: insights from the Association of British Clinical Diabetologists (ABCD) Nationwide Audit
    Shah, Najeeb
    Deshmukh, Harshal
    Wilmot, Emma G.
    Patmore, Jane
    Choudhary, Pratik
    Christian, Peter
    Herring, Roselle
    Furlong, Niall
    Saunders, Simon
    Narendran, Parth
    Barnes, Dennis J.
    Walton, Chris
    Ryder, Robert E. J.
    Sathyapalan, Thozhukat
    BRITISH JOURNAL OF DIABETES, 2021, 21 (02): : 192 - 197
  • [39] TWO YEARS OF FREESTYLE LIBRE (FSL) USE: IMPACT ON GLYCAEMIC CONTROL AND HYPOGLYCAEMIA AWARENESS IN PEOPLE WITH DIABETES: ASSOCIATION OF BRITISH CLINICAL DIABETOLOGISTS NATIONAL AUDIT
    Shah, N.
    Deshmukh, H.
    Wilmot, E.
    Pieri, B.
    Furlong, N.
    Walton, C.
    Patmore, J.
    Ryder, R.
    Sathyapalan, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A129 - A130
  • [40] The long-term impact of glucose monitoring with the FreeStyle Libre on glycaemic control and hypoglycaemia awareness in people with type 1 diabetes: Insights from the Association of British Clinical Diabetologists national audit
    Shah, Najeeb
    Deshmukh, Harshal
    Wilmot, Emma G.
    Patmore, Jane
    Christian, Peter
    Barnes, Dennis J.
    Walton, Chris
    Ryder, Robert E. J.
    Sathyapalan, Thozhukat
    DIABETIC MEDICINE, 2023, 40 (06)